GSK Looks at Acquisition for Inorganic Growth in India

British pharma major GlaxoSmithKline Pharmaceuticals is looking at acquiring brands and companies for an inorganic growth in the country post the product patent regime that comes into force this year. The Indian pharma industry is looking for consolidation in the post product patent regime and GSK wants to take advantage of that. Most Indian promoters of the company also want to take advantage of the regime and want to exit.

Silicon India (http://www.siliconindia.com/shownewsdata.asp?newsno=27255)